Evidence map›Paper›PMID 32833946›Full record

ArticlePancreas2020

Depression Before and After a Diagnosis of Pancreatic Cancer: Results From a National, Population-Based Study.

Talal Seoud, Aslam Syed, Neil Carleton, Caitlan Rossi, Barbara Kenner, Hassan Quershi, Mary Anand, Payal Thakkar, Shyam Thakkar

Open access · greenAbstract read
In one paragraph

Article in Pancreas, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 4 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 4 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Depression and increased cancer risk: a 10-year population-based cohort study.Social psychiatry and psychiatric epidemiology · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Talal SeoudFrom the Division of Gastroenterology and Hepatology, Stony Brook University Hospital, Long Island, NY.
Aslam Syed
Neil CarletonMedical Scientist Training Program, University of Pittsburgh School of Medicine.
Caitlan RossiMedicine Institute, Allegheny Health Network, Pittsburgh, PA.
Barbara KennerKenner Family Research Fund, New York, NY.
Hassan Quershi
Mary Anand
Payal ThakkarAllegheny Singer Research Institute, Allegheny Health Network, Pittsburgh, PA.
Shyam ThakkarAdjunct Faculty, Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh PA.
Stony Brook University Hospital · USAllegheny Health Network · USAllegheny-Singer Research Institute · USMetroHealth Medical Center · USUniversity of Pittsburgh · US

Funding

TRAINING PROGRAM FOR MD/PHD STUDENTST32GM008208 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI STEINMAN, RICHARD A · 1987 to 2021
$15.4M
NIGMS NIH HHS T32 GM008208
6 · The paper itself

Abstract

objectivesThe aim of this study was to evaluate depression in pancreatic cancer (PC) patients before and after a cancer diagnosis using a US-based healthcare database. We also sought to study the impact of treatment of depression in PC patients on all-cause mortality.

methodsPancreatic cancer patients with comorbid depression in Explorys (1999-2019) were compared with controls using odds ratios with 95% confidence intervals. Rates of depression diagnosed within 6 months, 1 year, and 3 years before and after a PC diagnosis were recorded. Patients who developed depression after a PC diagnosis were further categorized into those treated for depression using mental health professionals (MHPs), pharmacologic treatment, or both (2015-2019).

resultsOf the 62,450 PC patients, 10,220 (16.4%) were diagnosed with depression before PC and 8130 (13%) were diagnosed with depression after PC. Patients diagnosed with depression after PC had a significantly higher all-cause mortality than patients with PC alone (P < 0.0001). Involvement of MHP significantly improved all-cause mortality (P = 0.0041).

conclusionsMost post-PC depression is diagnosed in the first 6 months after a PC diagnosis. Although depression significantly increases PC mortality, integrating MHP in the care of PC patients with depression improves outcomes.

Indexed as

AdolescentAdultAgedAntidepressive AgentsAnxietyDepressionFatigueFemaleHumansMaleMiddle AgedPancreatic NeoplasmsQuality of LifeRisk FactorsSurvival RateTime FactorsAntidepressive Agents

Identifiers

PMID32833946
PMCPMC7450395
OpenAlexW3080963862

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.